Piramal Pharma has announced the appointment of OMD India, part of Omnicom Media Group for its integrated media duties. 

The agency will be responsible for strategic marketing and media efforts for Piramal Pharma’s portfolio of OTC brands, including Lacto Calamine, Little’s, Tetmosol, Polycrol, and women’s intimate health range like i-pill and i-activ, and will be managed out of the agency’s Mumbai office. 

OMD India also aims to enhance Piramal Pharma’s presence across markets, boost brand salience, drive consumer engagement, and enable impact-driven marketing strategy to be a driver for business growth. 

The account was won following a multi-agency pitch. 

Anisha Iyer, CEO, OMD India, said, “We are excited to embark on this partnership with Piramal Consumer Healthcare, a company that mirrors our commitment to innovation and excellence. This collaboration presents a significant opportunity to leverage our strategic acumen and deep market intelligence to elevate Piramal's impressive portfolio of brands to new heights. Together, we aim to craft media strategies that go beyond visibility—building lasting trust and loyalty with consumers across India and shaping a future of sustained growth and impact.”